Exhibit 4.36

                        AMENDMENT NO. 1 TO THE WARRANT

       This  Amendment  No. 1, dated as of August 19, 2002 (this "Amendment No.
1"), is to the Warrant, dated  as  of  July  30,  2002, (the "Warrant") between
Molecular Diagnostics, Inc., a Delaware corporation  (the  "Company"),  and the
holders of the Warrants (the "Investors").

                                  WITNESSETH:

       WHEREAS,  the  Investors  purchased  the  Warrants  in connection with a
bridge financing that closed June 30, 2002;

       WHEREAS, the Investors have agreed to amend the maturity date of certain
Promissory Notes purchased in the bridge financing; and

       WHEREAS, pursuant to and in compliance with the provisions of Section 21
of the Warrants, the Company and the Investors desire to amend  the Warrants as
hereinafter set forth.

       NOW,  THEREFORE, in consideration of the premises and agreements  herein
contained, the Company and the Investors agree as follows:

       1.    The  Exercise  Price  of  the  Warrants is adjusted from $0.65 per
share to $0.25 per share.

       2.    Capitalized terms not defined herein shall have the meanings given
them in the Warrants.

       3.    This Amendment No. 1 may be executed in any number of counterparts
and  each  of  such counterparts shall for all purposes  be  deemed  to  be  an
original, and all  such  counterparts shall together constitute but one and the
same instrument.






IN WITNESS WHEREOF, the parties have caused this Amendment No. 1 to be duly
executed and attested as of the ____ day of August, 2002.


                                        MOLECULAR DIAGNOSTICS, INC.


                                        By:   _________________________________
                                              Name:  Peter P. Gombrich
                                              Title: Chief Executive Officer
                                                     and President



                                 INVESTOR:



                                        By:   _________________________________